TGFB1 Protein (AA 279-390)
Kurzübersicht für TGFB1 Protein (AA 279-390) (ABIN4371491)
Target
Alle TGFB1 Proteine anzeigenProtein-Typ
Spezies
Quelle
Reinheit
-
-
Proteineigenschaft
- AA 279-390
-
Verwendungszweck
- Recombinant Mouse Transforming Growth Factor β-1/TGFβ1/TGFB1
-
Sequenz
- ALDTNYCFSS TEKNCCVRQL YIDFRKDLGW KWIHEPKGYH ANFCLGPCPY IWSLDTQYSK VLALYNQHNP GASASPCCVP QALEPLPIVY YVGRKPKVEQ LSNMIVRSCK CS
-
Produktmerkmale
-
Recombinant Mouse Transforming Growth Factor β-1/TGFβ1/TGFB1
-
Sterilität
- 0.2 μm filtered
-
Endotoxin-Niveau
- Less than 0.1 ng/μg (1 IEU/μg) as determined by LAL test
-
-
Möchten Sie weitere Optionen für dieses Protein ?
!Entdecken Sie unsere vordefinierten maßgeschneiderten Proteine und Proteinservices!Ihr Projekt erfordert weitere Anpassungen? Kontaktieren Sie uns und entdecken Sie unsere maßgeschneiderten Proteinlösungen
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
-
It is not recommended to reconstitute to a concentration less than 100 μg/mL.
Dissolve the lyophilized protein in ddH2O.
Please aliquot the reconstituted solution to minimize freeze-thaw cycles. -
Buffer
- Lyophilized from a 0.2 μm filtered solution of 50 mM Glycine,150 mM NaCl, pH 2.5.
-
Handhabung
- Always centrifuge tubes before opening. Do not mix by vortex or pipetting.
-
Lagerung
- 4 °C/-20 °C/-80 °C
-
Informationen zur Lagerung
-
Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks.
Reconstituted protein solution can be stored at 4-7°C for 2-7 days.
Aliquots of reconstituted samples are stable at < -20°C for 3 months.
-
-
- TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
-
Andere Bezeichnung
- Transforming Growth Factor beta-1
-
Molekulargewicht
- 12.8 kDa
-
UniProt
- P04202
-
Pathways
- EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagie, Cancer Immune Checkpoints
Target
-